Data as of Sep 19
| -0.04 / -10.26%|
The 1 analysts offering 12-month price forecasts for Aeolus Pharmaceuticals Inc have a median target of 1.25, with a high estimate of 1.25 and a low estimate of 1.25. The median estimate represents a +257.14% increase from the last price of 0.35.
The current consensus among 1 polled investment analysts is to Buy stock in Aeolus Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.